Lymphoma

Researchers found that the addition of brentuximab vedotin to standard chemotherapy improves overall survival in people with Hodgkin Lymphoma.

A recent study investigates the reasons for decreasing remission rates for patients with non-Hodgkin lymphoma treated with CAR-T cell therapy.

Hematologist Dr. Carrie Thompson discusses what people can expect after treatment for lymphoma and how to achieve the best quality of life.

The story of Brooke Michael's journey to successful CAR-T cell therapy treatment after being diagnosed with primary B-cell lymphoma at 17.

Learn about CAR-T cell therapy, a personalized treatment giving hope to patients diagnosed with various lymphomas.

Dr. Dawn Mussallem, a cancer survivor and heart transplant recipient, successfully completed the 26.2 With Donna marathon on Feb. 6.

The American Society of Hematology (ASH) recognized Mayo Clinic hematologist Stephen Ansell, M.D., with the highly distinguished Ernest Beutler Lecture and Prize in recognition of his significant contributions to the field of lymphoma research.

Mom of five Felicia Curtis knew she had to fight when she was diagnosed with non-Hodgkin's lymphoma in 2017, when she was 20 weeks pregnant with her youngest child.

A study led by Mayo Clinic researchers Zhi Zhang Yang, M.D., and Stephen M. Ansell, M.D., Ph.D., has found that healthy white blood cells called[...]

Stephen M. Ansell, M.D., Ph.D., a hematologist at Mayo Clinic in Rochester, Minnesota, discusses his lymphoma research.